James Thomas Mccracken
#142,709
Most Influential Person Now
James Thomas Mccracken's AcademicInfluence.com Rankings
James Thomas Mccrackenpsychology Degrees
Psychology
#3077
World Rank
#3509
Historical Rank
Clinical Psychology
#276
World Rank
#280
Historical Rank
Download Badge
Psychology
Why Is James Thomas Mccracken Influential?
(Suggest an Edit or Addition)James Thomas Mccracken's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Cognitive behavioral therapy, sertraline, or a combination in childhood anxiety. (2008) (1249)
- Risperidone in children with autism and serious behavioral problems. (2002) (1186)
- Concurrent Validity of the Anxiety Disorders Section of the Anxiety Disorders Interview Schedule for DSM-IV: Child and Parent Versions (2002) (878)
- HHS Public Access (2018) (765)
- Genomic Relationships, Novel Loci, and Pleiotropic Mechanisms across Eight Psychiatric Disorders (2019) (724)
- Practice parameter for the assessment and treatment of children and adolescents with autism spectrum disorder. (2014) (576)
- Switching to another SSRI or to venlafaxine with or without cognitive behavioral therapy for adolescents with SSRI-resistant depression: the TORDIA randomized controlled trial. (2008) (570)
- Parent-Rated Anxiety Symptoms in Children with Pervasive Developmental Disorders: Frequency and Association with Core Autism Symptoms and Cognitive Functioning (2008) (558)
- Functional impairment in children and adolescents with obsessive-compulsive disorder. (2003) (513)
- Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity. (2005) (486)
- Fluvoxamine for the treatment of anxiety disorders in children and adolescents. The Research Unit on Pediatric Psychopharmacology Anxiety Study Group. (2001) (453)
- Catecholamines in attention-deficit hyperactivity disorder: current perspectives. (1996) (434)
- Lack of efficacy of citalopram in children with autism spectrum disorders and high levels of repetitive behavior: citalopram ineffective in children with autism. (2009) (425)
- Efficacy and safety of immediate-release methylphenidate treatment for preschoolers with ADHD. (2006) (414)
- Psychiatric comorbidity in adult attention deficit hyperactivity disorder: findings from multiplex families. (2005) (412)
- The Texas Children's Medication Algorithm Project: revision of the algorithm for pharmacotherapy of attention-deficit/hyperactivity disorder. (2006) (409)
- Risperidone for the core symptom domains of autism: results from the study by the autism network of the research units on pediatric psychopharmacology. (2005) (406)
- Clinical characteristics of anxiety disordered youth. (2010) (342)
- Total and regional brain volumes in a population-based normative sample from 4 to 18 years: the NIH MRI Study of Normal Brain Development. (2012) (329)
- Child/Adolescent Anxiety Multimodal Study (CAMS): rationale, design, and methods (2010) (318)
- A genomewide scan for loci involved in attention-deficit/hyperactivity disorder. (2002) (315)
- Impairment in childhood anxiety disorders: preliminary examination of the child anxiety impact scale-parent version. (2004) (301)
- Revealing the complex genetic architecture of obsessive–compulsive disorder using meta-analysis (2018) (294)
- Remission after acute treatment in children and adolescents with anxiety disorders: findings from the CAMS. (2011) (286)
- Partitioning the Heritability of Tourette Syndrome and Obsessive Compulsive Disorder Reveals Differences in Genetic Architecture (2013) (280)
- Suicide Attempts and Nonsuicidal Self-Injury in the Treatment of Resistant Depression in Adolescents: Findings from the TORDIA Study (2012) (280)
- Suicide attempts and nonsuicidal self-injury in the treatment of resistant depression in adolescents: findings from the TORDIA study. (2011) (277)
- Genome-wide association study of obsessive-compulsive disorder (2013) (256)
- Prevalence and description of selective mutism in a school-based sample. (2002) (246)
- Genetic linkage of attention-deficit/hyperactivity disorder on chromosome 16p13, in a region implicated in autism. (2002) (244)
- Genome-Wide Association Study in Obsessive-Compulsive Disorder: Results from the OCGAS (2014) (244)
- Decreased Anterior Cingulate Myo-inositol/Creatine Spectroscopy Resonance with Lithium Treatment in Children with Bipolar Disorder (2001) (237)
- A genomewide scan for attention-deficit/hyperactivity disorder in an extended sample: suggestive linkage on 17p11. (2003) (233)
- Safety and tolerability of methylphenidate in preschool children with ADHD. (2006) (232)
- Gastrointestinal Symptoms in a Sample of Children with Pervasive Developmental Disorders (2009) (227)
- Is obsessive–compulsive disorder an anxiety disorder, and what, if any, are spectrum conditions? A family study perspective (2011) (224)
- Controlled comparison of family cognitive behavioral therapy and psychoeducation/relaxation training for child obsessive-compulsive disorder. (2011) (221)
- Deficit/Hyperactivity Disorder (2000) (220)
- Autism, affective disorders, and social phobia. (1995) (212)
- Gene variants of brain dopamine pathways and smoking-induced dopamine release in the ventral caudate/nucleus accumbens. (2006) (211)
- Cortical sulcal maps in autism. (2003) (207)
- Stimulant-related reductions of growth rates in the PATS. (2006) (206)
- SPARK: A US Cohort of 50,000 Families to Accelerate Autism Research (2018) (206)
- Risperidone treatment of autistic disorder: longer-term benefits and blinded discontinuation after 6 months. (2005) (205)
- Hoarding in obsessive-compulsive disorder: results from the OCD Collaborative Genetics Study. (2007) (205)
- Predictors of spontaneous and systematically assessed suicidal adverse events in the treatment of SSRI-resistant depression in adolescents (TORDIA) study. (2009) (200)
- Predictors and moderators of treatment response in childhood anxiety disorders: results from the CAMS trial. (2014) (197)
- Adrenal gland volume in major depression. Increase during the depressive episode and decrease with successful treatment. (1995) (197)
- Treatment of selective serotonin reuptake inhibitor-resistant depression in adolescents: predictors and moderators of treatment response. (2009) (188)
- Mapping cortical asymmetry and complexity patterns in normal children (2001) (186)
- The Preschool Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS) 6-year follow-up. (2013) (185)
- Meta‐analysis of genome‐wide linkage scans of attention deficit hyperactivity disorder (2008) (185)
- Evidence for linkage of a tandem duplication polymorphism upstream of the dopamine D4 receptor gene (DRD4) with attention deficit hyperactivity disorder (ADHD) (2000) (184)
- Correlates of accommodation of pediatric obsessive-compulsive disorder: parent, child, and family characteristics. (2008) (180)
- Sapap3 and pathological grooming in humans: Results from the OCD collaborative genetics study (2009) (179)
- Familial clustering of symptoms and disruptive behaviors in multiplex families with attention-deficit/hyperactivity disorder. (2000) (174)
- Comparative effectiveness of biomarkers and clinical indicators for predicting outcomes of SSRI treatment in Major Depressive Disorder: Results of the BRITE-MD study (2009) (173)
- Exploring the Manifestations of Anxiety in Children with Autism Spectrum Disorders (2013) (172)
- Children's Yale-Brown Obsessive Compulsive Scale modified for pervasive developmental disorders. (2006) (171)
- Prevalence and psychiatric comorbidity of attention-deficit/hyperactivity disorder in an adolescent Finnish population. (2007) (168)
- Reduced white matter integrity in attention-deficit hyperactivity disorder (2008) (168)
- Research Units on Pediatric Psychopharmacology (RUPP) Autism Network. Background and rationale for an initial controlled study of risperidone. (2000) (164)
- Open trial of cognitive behavior therapy for childhood obsessive-compulsive disorder. (2002) (163)
- Familiality of Factor Analysis-Derived YBOCS Dimensions in OCD-Affected Sibling Pairs from the OCD Collaborative Genetics Study (2007) (163)
- Autism spectrum disorder: Consensus guidelines on assessment, treatment and research from the British Association for Psychopharmacology (2018) (161)
- The association of DRD4 and novelty seeking is found in a nonhuman primate model (2007) (160)
- Significant linkage to compulsive hoarding on chromosome 14 in families with obsessive-compulsive disorder: results from the OCD Collaborative Genetics Study. (2007) (158)
- Widespread cortical thinning is a robust anatomical marker for attention-deficit/hyperactivity disorder. (2009) (155)
- Acute and long-term safety and tolerability of risperidone in children with autism. (2005) (150)
- Genomewide linkage scan for obsessive-compulsive disorder: evidence for susceptibility loci on chromosomes 3q, 7p, 1q, 15q, and 6q (2006) (145)
- Validity of the autism diagnostic interview-revised. (2006) (145)
- Fluoxetine treatment for prevention of relapse of depression in children and adolescents: a double-blind, placebo-controlled study. (2004) (144)
- Effects of Short- and Long-Term Risperidone Treatment on Prolactin Levels in Children with Autism (2007) (142)
- Clinical presentation of attention-deficit/hyperactivity disorder in preschool children: the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS). (2007) (141)
- The Texas Children's Medication Algorithm Project: Report of the Texas Consensus Conference Panel on Medication Treatment of Childhood Attention-Deficit/Hyperactivity Disorder. Part I. Attention-Deficit/Hyperactivity Disorder. (2000) (141)
- Testosterone-related cortical maturation across childhood and adolescence. (2012) (141)
- Trajectories of change in youth anxiety during cognitive-behavior therapy. (2015) (140)
- Attention deficit hyperactivity disorder: fine mapping supports linkage to 5p13, 6q12, 16p13, and 17p11. (2004) (138)
- Second-generation antipsychotic medications in children and adolescents. (2004) (138)
- Family-based genome-wide association scan of attention-deficit/hyperactivity disorder. (2010) (138)
- Further development of YBOCS dimensions in the OCD Collaborative Genetics Study: Symptoms vs. categories (2008) (138)
- 24- and 36-week outcomes for the Child/Adolescent Anxiety Multimodal Study (CAMS). (2014) (137)
- CYP2D6 and clinical response to atomoxetine in children and adolescents with ADHD. (2007) (136)
- Rationale, design, and methods of the Preschool ADHD Treatment Study (PATS). (2006) (136)
- Positive Effects of Methylphenidate on Social Communication and Self-Regulation in Children with Pervasive Developmental Disorders and Hyperactivity (2009) (133)
- A Laboratory School Comparison of Mixed Amphetamine Salts Extended Release (Adderall XR®) and Atomoxetine (Strattera®) in School-Aged Children With Attention Deficit/Hyperactivity Disorder (2005) (132)
- Cortical activity patterns in ADHD during arousal, activation and sustained attention (2009) (132)
- Treatment of Resistant Depression in Adolescents (TORDIA): week 24 outcomes. (2010) (130)
- Mental health problems and service use among female juvenile offenders: their relationship to criminal history. (2001) (129)
- Proton magnetic resonance spectroscopy of bipolar disorder versus intermittent explosive disorder in children and adolescents. (2003) (128)
- Reciprocal influences among adrenocortical activation, psychosocial processes, and the behavioral adjustment of clinic-referred children. (1996) (127)
- Positive Effects of Methylphenidate on Inattention and Hyperactivity in Pervasive Developmental Disorders: An Analysis of Secondary Measures (2007) (127)
- Cross-disorder genome-wide analyses suggest a complex genetic relationship between Tourette's syndrome and OCD. (2015) (123)
- Pharmacogenetics of methylphenidate response in preschoolers with ADHD. (2006) (123)
- Extended-Release Guanfacine for Hyperactivity in Children With Autism Spectrum Disorder. (2015) (123)
- Electroencephalography Correlates of Spatial Working Memory Deficits in Attention-Deficit/Hyperactivity Disorder: Vigilance, Encoding, and Maintenance (2014) (123)
- Adrenal gland volume in major depression: Relationship to basal and stimulated pituitary-adrenal cortical axis function (1996) (123)
- Brain abnormalities in early-onset schizophrenia spectrum disorder observed with statistical parametric mapping of structural magnetic resonance images. (2000) (123)
- Weight and leptin changes among risperidone-treated youths with autism: 6-month prospective data. (2004) (122)
- Sequential pharmacotherapy for children with comorbid attention-deficit/hyperactivity and anxiety disorders. (2005) (120)
- Characterization of the Theta to Beta Ratio in ADHD (2013) (120)
- Biased paternal transmission of SNAP-25 risk alleles in attention-deficit hyperactivity disorder (2003) (116)
- Assessment in Multisite Randomized Clinical Trials of Patients with Autistic Disorder: The Autism RUPP Network (2000) (115)
- Association of the cannabinoid receptor gene (CNR1) with ADHD and post‐traumatic stress disorder (2008) (114)
- Relationship of family environment and parental psychiatric diagnosis to impairment in ADHD. (2006) (112)
- Transmission disequilibrium testing of dopamine-related candidate gene polymorphisms in ADHD: confirmation of association of ADHD with DRD4 and DRD5 (2004) (112)
- Analog classroom assessment of a once-daily mixed amphetamine formulation, SLI381 (Adderall XR), in children with ADHD. (2003) (112)
- Parent versus teacher ratings of attention-deficit/hyperactivity disorder symptoms in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS). (2007) (111)
- Long-term outcome of adolescent depression initially resistant to selective serotonin reuptake inhibitor treatment: a follow-up study of the TORDIA sample. (2011) (110)
- A family‐based association study of the glutamate transporter gene SLC1A1 in obsessive–compulsive disorder in 378 families (2009) (110)
- A prospective open trial of guanfacine in children with pervasive developmental disorders. (2006) (110)
- Copy number variation in obsessive-compulsive disorder and tourette syndrome: a cross-disorder study. (2014) (109)
- STX209 (Arbaclofen) for Autism Spectrum Disorders: An 8-Week Open-Label Study (2014) (107)
- Monoamine Oxidase A and Catechol-O-Methyltransferase Functional Polymorphisms and the Placebo Response in Major Depressive Disorder (2009) (102)
- Clinical Pharmacogenetics Implementation Consortium Guideline for Cytochrome P450 (CYP)2D6 Genotype and Atomoxetine Therapy (2019) (102)
- Long-term tolerability and effectiveness of once-daily mixed amphetamine salts (Adderall XR) in children with ADHD. (2005) (101)
- Proton magnetic resonance spectroscopic imaging of the brain in childhood autism (2003) (100)
- The Texas Children's Medication Algorithm Project: Report of the Texas Consensus Conference Panel on Medication Treatment of Childhood Attention-Deficit/Hyperactivity Disorder. Part II: Tactics. Attention-Deficit/Hyperactivity Disorder. (2000) (98)
- Elevated Glutamatergic Compounds in Pregenual Anterior Cingulate in Pediatric Autism Spectrum Disorder Demonstrated by 1H MRS and 1H MRSI (2012) (96)
- Autism spectrum disorders: an overview on diagnosis and treatment. (2013) (94)
- Genome-wide scan of reading ability in affected sibling pairs with attention-deficit/hyperactivity disorder: unique and shared genetic effects (2004) (92)
- Temperament and character profiles and the dopamine D4 receptor gene in ADHD. (2005) (91)
- Potential adverse effects of amphetamine treatment on brain and behavior: a review (2010) (90)
- Atypical Brain Activation During Simple & Complex Levels of Processing in Adult ADHD (2007) (89)
- Gender differences in the left inferior frontal gyrus in normal children (2004) (89)
- Risperidone and adaptive behavior in children with autism. (2006) (88)
- Meta‐analysis of association between obsessive‐compulsive disorder and the 3′ region of neuronal glutamate transporter gene SLC1A1 (2013) (86)
- Obsessive–compulsive disorder: subclassification based on co-morbidity (2008) (86)
- Methodological issues and controversies in clinical trials with child and adolescent patients with bipolar disorder: report of a consensus conference. (2003) (86)
- Cerebellar vermis lobules VIII — X in autism (1999) (85)
- Methylphenidate effects on functional outcomes in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS). (2007) (85)
- Assessing Anxiety in Youth with the Multidimensional Anxiety Scale for Children (2014) (84)
- Comorbidity moderates response to methylphenidate in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS). (2007) (83)
- Comprehensive family‐based association study of the glutamate transporter gene SLC1A1 in obsessive‐compulsive disorder (2011) (83)
- Measuring repetitive behaviors as a treatment endpoint in youth with autism spectrum disorder (2015) (83)
- The role of treatment expectancy in youth receiving exposure-based CBT for obsessive compulsive disorder. (2011) (83)
- Psychiatric consultation in severe and profound mental retardation. (1994) (81)
- Correlates of insight among youth with obsessive-compulsive disorder. (2010) (81)
- Interactive Effects of Dehydroepiandrosterone and Testosterone on Cortical Thickness during Early Brain Development (2013) (81)
- Impact of physical and sexual abuse on treatment response in the Treatment of Resistant Depression in Adolescent Study (TORDIA). (2011) (81)
- Executive functioning among Finnish adolescents with attention-deficit/hyperactivity disorder. (2007) (80)
- Treatment of pediatric anxiety disorders: an open-label extension of the research units on pediatric psychopharmacology anxiety study. (2002) (80)
- Transcranial magnetic stimulation in autism spectrum disorder: Challenges, promise, and roadmap for future research (2016) (78)
- The OCD collaborative genetics study: Methods and sample description (2006) (78)
- Review of safety assessment methods used in pediatric psychopharmacology. (2003) (78)
- A testosterone-related structural brain phenotype predicts aggressive behavior from childhood to adulthood (2016) (77)
- Comparison of clinical features among youth with tic disorders, obsessive–compulsive disorder (OCD), and both conditions (2010) (76)
- Pharmacokinetics of SLI381 (ADDERALL XR), an extended-release formulation of Adderall. (2003) (75)
- Defining treatment response and remission in child anxiety: signal detection analysis using the pediatric anxiety rating scale. (2013) (73)
- Decreased Callosal Thickness in Attention-Deficit/Hyperactivity Disorder (2009) (71)
- Relationship between ethnicity and sleep patterns in normal controls: implications for psychopathology and treatment. (1999) (70)
- Atypical alpha asymmetry in adults with ADHD (2009) (69)
- Effectiveness of Methylphenidate in the 10-Month Continuation Phase of the Preschoolers with ADHD Treatment Study (PATS) (2007) (67)
- Academic Impairment and Impact of Treatments Among Youth with Anxiety Disorders (2015) (67)
- Large-scale targeted sequencing identifies risk genes for neurodevelopmental disorders (2020) (67)
- Exome sequencing of 457 autism families recruited online provides evidence for autism risk genes (2019) (66)
- Neurocognitive correlates of child obsessive compulsive disorder and Tourette syndrome (2007) (66)
- CBCL pediatric bipolar disorder profile and ADHD: comorbidity and quantitative trait loci analysis. (2008) (65)
- Association of SLC6A4 variants with obsessive-compulsive disorder in a large multi-center US family study (2009) (64)
- How can we improve the assessment of safety in child and adolescent psychopharmacology? (2003) (64)
- Effectiveness and tolerability of open label olanzapine in children and adolescents with Tourette syndrome. (2008) (63)
- Tolerability, Safety, and Benefits of Risperidone in Children and Adolescents with Autism: 21-Month Follow-up After 8-Week Placebo-Controlled Trial. (2015) (63)
- Somatic Complaints in Anxious Youth (2014) (63)
- Mapping Cortical and Subcortical Asymmetry in Obsessive-Compulsive Disorder: Findings From the ENIGMA Consortium (2020) (61)
- Genome-wide association study of the child behavior checklist dysregulation profile. (2011) (61)
- Familial clustering and DRD4 effects on electroencephalogram measures in multiplex families with attention deficit/hyperactivity disorder. (2010) (61)
- Medial temporal lobe in childhood-onset schizophrenia (2001) (60)
- Cognitive effects of risperidone in children with autism and irritable behavior. (2008) (60)
- Therapist-Reported Features of Exposure Tasks That Predict Differential Treatment Outcomes for Youth With Anxiety. (2017) (60)
- An exploration of concomitant psychiatric disorders in children with autism spectrum disorder. (2019) (59)
- Searching for moderators and mediators of pharmacological treatment effects in children and adolescents with anxiety disorders. (2003) (59)
- Psychopharmacology of autism spectrum disorders. (2012) (58)
- Children's Yale-Brown obsessive compulsive scale in autism spectrum disorder: component structure and correlates of symptom checklist. (2014) (58)
- Weight Gain and Metabolic Consequences of Risperidone in Young Children With Autism Spectrum Disorder. (2016) (58)
- Moderators, mediators, and other predictors of risperidone response in children with autistic disorder and irritability. (2010) (58)
- Targeted Family Intervention for Complex Cases of Pediatric Obsessive-Compulsive Disorder: A Randomized Controlled Trial. (2017) (57)
- Manganese in children with attention-deficit/hyperactivity disorder: relationship with methylphenidate exposure. (2010) (56)
- Dietary status and impact of risperidone on nutritional balance in children with autism: A pilot study (2006) (56)
- Attention-deficit/hyperactivity disorder: perspectives from neuroimaging. (2000) (55)
- Parental Anxiety as a Predictor of Medication and CBT Response for Anxious Youth (2015) (55)
- Atomoxetine Treatment of ADHD in Children With Comorbid Tourette Syndrome (2008) (55)
- Moderation of antipsychotic-induced weight gain by energy balance gene variants in the RUPP autism network risperidone studies (2013) (54)
- ADHD familial loading and abnormal EEG alpha asymmetry in children with ADHD. (2010) (54)
- Factor structure of parent- and teacher-rated attention-deficit/hyperactivity disorder symptoms in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS). (2007) (53)
- Clinical and Cognitive Correlates of Depressive Symptoms Among Youth with Obsessive Compulsive Disorder (2010) (52)
- Baseline factors predicting placebo response to treatment in children and adolescents with autism spectrum disorders: a multisite randomized clinical trial. (2013) (52)
- Parsing heterogeneity in attention‐deficit hyperactivity disorder using EEG‐based subgroups (2018) (50)
- Overweight and obese status in children with autism spectrum disorder and disruptive behavior (2018) (49)
- Examination of aggression and self-injury in children with autism spectrum disorders and serious behavioral problems. (2014) (49)
- A multicenter examination and strategic revisions of the Yale Global Tic Severity Scale (2018) (48)
- Brief Report: Social Disability in Autism Spectrum Disorder: Results from Research Units on Pediatric Psychopharmacology (RUPP) Autism Network Trials (2013) (48)
- A screen of SLC1A1 for OCD‐related alleles (2010) (48)
- Diminished Gray Matter Within the Hypothalamus in Autism Disorder: A Potential Link to Hormonal Effects? (2011) (48)
- Antidepressant Exposure as a Predictor of Clinical Outcomes in the Treatment of Resistant Depression in Adolescents (TORDIA) Study (2011) (48)
- Child/Adolescent anxiety multimodal study: evaluating safety. (2015) (47)
- Methodological issues in designing a multisite trial of risperidone in children and adolescents with autism. (2001) (45)
- 1H MRSI evidence of metabolic abnormalities in childhood-onset schizophrenia (2004) (45)
- Graph-theoretical analysis of resting-state fMRI in pediatric obsessive-compulsive disorder. (2016) (45)
- A Single Dose, Randomized, Controlled Proof-Of-Mechanism Study of a Novel Vasopressin 1a Receptor Antagonist (RG7713) in High-Functioning Adults with Autism Spectrum Disorder (2016) (44)
- Development and validation of an item response theory‐based Social Responsiveness Scale short form (2017) (44)
- A randomized, placebo-controlled trial of extended-release guanfacine in children with autism spectrum disorder and ADHD symptoms: an analysis of secondary outcome measures (2018) (44)
- 1H MRSI of middle frontal gyrus in pediatric ADHD. (2013) (44)
- Factor structure and psychometric properties of the revised Home Situations Questionnaire for autism spectrum disorder: The Home Situations Questionnaire-Autism Spectrum Disorder (2016) (43)
- Polygenic risk score and heritability estimates reveals a genetic relationship between ASD and OCD (2017) (43)
- Adult attention deficit hyperactivity disorder: moving beyond DSM-IV. (2006) (43)
- Atypical brain laterality in adults with ADHD during dichotic listening for emotional intonation and words (2006) (43)
- The therapeutic relationship in cognitive-behavioral therapy and pharmacotherapy for anxious youth. (2013) (42)
- Sex-specific clinical correlates of hoarding in obsessive-compulsive disorder. (2008) (42)
- Incremental cost-effectiveness of combined therapy vs medication only for youth with selective serotonin reuptake inhibitor-resistant depression: treatment of SSRI-resistant depression in adolescents trial findings. (2011) (42)
- Brain N-acetyl aspartate concentrations measured by H MRS are reduced in adult male rats subjected to perinatal stress: preliminary observations and hypothetical implications for neurodevelopmental disorders. (1999) (42)
- Cognitive functioning in affected sibling pairs with ADHD: familial clustering and dopamine genes. (2008) (42)
- Whole genome association analysis of treatment response in obsessive-compulsive disorder (2015) (42)
- A Meta-Analysis of D-Cycloserine in Exposure-Based Treatment: Moderators of Treatment Efficacy, Response, and Diagnostic Remission. (2017) (41)
- Extinction learning in childhood anxiety disorders, obsessive compulsive disorder and post-traumatic stress disorder: implications for treatment (2016) (41)
- Sleep electroencephalographic abnormalities in adolescent depressives: Effects of scopolamine (1997) (41)
- Trial Design Challenges When Combining Medication and Parent Training in Children with Pervasive Developmental Disorders (2009) (40)
- Ecopipam, a D1 receptor antagonist, for treatment of tourette syndrome in children: A randomized, placebo‐controlled crossover study (2018) (40)
- Developing methodologies for monitoring long-term safety of psychotropic medications in children: report on the NIMH conference, September 25, 2000. (2003) (40)
- Evidence for potential relationship between SLC1A1 and a putative genetic linkage region on chromosome 14q to obsessive‐compulsive disorder with compulsive hoarding (2008) (40)
- Sex-specific associations of testosterone with prefrontal-hippocampal development and executive function (2017) (40)
- Positive effects of methylphenidate on hyperactivity are moderated by monoaminergic gene variants in children with autism spectrum disorders (2013) (40)
- Prenatal stress is associated with depression-related electroencephalographic sleep changes in adult male rats: A preliminary report (1999) (39)
- Impaired linguistic processing and atypical brain laterality in adults with ADHD (2005) (37)
- Abnormal development of the anterior cingulate in childhood-onset schizophrenia: a preliminary quantitative MRI study (2005) (37)
- Safety issues with drug therapies for autism spectrum disorders. (2005) (36)
- Hoarding in Children and Adolescents with Obsessive-Compulsive Disorder. (2014) (36)
- REM sleep in depression is influenced by ethnicity (1999) (36)
- Atypical EEG beta asymmetry in adults with ADHD (2010) (36)
- Alpha desynchronization and frontoparietal connectivity during spatial working memory encoding deficits in ADHD: A simultaneous EEGfMRI study (2016) (34)
- Demographic and clinical characteristics associated with treatment status in family members with obsessive‐compulsive disorder (2008) (34)
- Research knowledge among parents of children participating in a randomized clinical trial. (2005) (33)
- Genome-wide association study of obsessive-compulsive disorder (2013) (33)
- Assessment of attention deficit hyperactivity disorder: a review of recent literature. (2000) (33)
- MRSI correlates of cognitive–behavioral therapy in pediatric obsessive–compulsive disorder (2012) (33)
- The diffusion tensor imaging (DTI) component of the NIH MRI study of normal brain development (PedsDTI) (2016) (32)
- Glutamate in Pediatric Obsessive-Compulsive Disorder and Response to Cognitive-Behavioral Therapy: Randomized Clinical Trial (2017) (32)
- S-adenosyl-L-methionine (SAM) in adults with ADHD, RS: preliminary results from an open trial. (1990) (32)
- Prolactin in childhood obsessive-compulsive disorder: clinical correlates and response to clomipramine. (1991) (32)
- What’s missing in autism spectrum disorder motor assessments? (2018) (31)
- Pharmacotherapy of the Preschool ADHD Treatment Study (PATS) Children Growing Up. (2015) (31)
- A candidate gene analysis of methylphenidate response in attention-deficit/hyperactivity disorder. (2009) (31)
- Effects of methamphetamine abuse and serotonin transporter gene variants on aggression and emotion-processing neurocircuitry (2012) (30)
- Agreement between therapists, parents, patients, and independent evaluators on clinical improvement in pediatric obsessive-compulsive disorder. (2012) (30)
- Gender differences in genetic linkage and association on 11p15 in obsessive–compulsive disorder families (2009) (30)
- Relationship between REM sleep latency and nocturnal cortisol concentrations in depressed patients (1992) (30)
- Parent satisfaction in a multi-site acute trial of risperidone in children with autism: a social validity study (2007) (29)
- Saliva and serum cortisol dynamics following intravenous dexamethasone in normal volunteers. (1989) (29)
- Effects of d-Methylphenidate, Guanfacine, and Their Combination on Electroencephalogram Resting State Spectral Power in Attention-Deficit/Hyperactivity Disorder. (2016) (29)
- Placebo Response in Pediatric Anxiety Disorders: Results from the Child/Adolescent Anxiety Multimodal Study. (2017) (29)
- Combined Stimulant and Guanfacine Administration in Attention-Deficit/Hyperactivity Disorder: A Controlled, Comparative Study. (2016) (28)
- Parental bonding and hoarding in obsessive-compulsive disorder. (2017) (28)
- An investigation of doubt in obsessive-compulsive disorder. (2017) (27)
- Differential response of rapid eye movement sleep to cholinergic blockade by scopolamine in currently depressed, remitted, and normal control subjects (1997) (27)
- Risperidone-related improvement of irritability in children with autism is not associated with changes in serum of epidermal growth factor and interleukin-13. (2011) (26)
- Genome-wide association study of intelligence: additive effects of novel brain expressed genes. (2012) (26)
- Atomoxetine treatment of ADHD in children with comorbid Tourette syndrome. (2008) (26)
- Child and Adolescent Adherence With Cognitive Behavioral Therapy for Anxiety: Predictors and Associations With Outcomes (2019) (26)
- Effectiveness of methylphenidate in the 10-month continuation phase of the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS). (2007) (26)
- Possible influence of variant of the P-glycoprotein gene (MDR1/ABCB1) on clinical response to guanfacine in children with pervasive developmental disorders and hyperactivity. (2010) (26)
- Electroencephalographic sleep and urinary free cortisol in adolescent depression: A preliminary report of changes from episode to recovery (1997) (25)
- Co-Occurrence of ADHD and High IQ (2011) (24)
- Separation anxiety disorder in OCD (2011) (24)
- Nimodipine treatment of an adolescent with ultradian cycling bipolar affective illness. (1999) (24)
- Pilot randomized trial of bupropion for adolescent methamphetamine abuse/dependence. (2013) (23)
- Integrating de novo and inherited variants in 42,607 autism cases identifies mutations in new moderate-risk genes (2021) (23)
- The Epidemiology of Child and Adolescent Mood Disorders (1992) (23)
- Mood stabilizers in the treatment of juvenile bipolar disorder. Advances and controversies. (2000) (23)
- OBSESSIVE–COMPULSIVE PERSONALITY DISORDER: EVIDENCE FOR TWO DIMENSIONS (2016) (23)
- Abnormal ACTH and prolactin responses to fenfluramine in rats exposed to single and multiple doses of MDMA (1997) (23)
- Under Recognition of Prenatal Alcohol Exposure in a Child Inpatient Psychiatric Setting (2006) (23)
- Alpha modulation during working memory encoding predicts neurocognitive impairment in ADHD. (2019) (23)
- Nomifensine Maleate in Adult Attention Deficit Disorder (1989) (23)
- The Potential of Repetitive Transcranial Magnetic Stimulation for Autism Spectrum Disorder: A Consensus Statement (2019) (23)
- A two-part model of stimulant action on attention-deficit hyperactivity disorder in children. (1991) (22)
- A probabilistic and individualized approach for predicting treatment gains: an extension and application to anxiety disordered youth. (2014) (22)
- A potential electroencephalography and cognitive biosignature for the child behavior checklist-dysregulation profile. (2013) (22)
- Neuroendocrine aspects of primary endogenous depression: XII. Receiver operating characteristic and kappa analyses of serum and urine cortisol measures in patients and matched controls (1992) (21)
- Refining the ADHD phenotype using affected sibling pair families. (2001) (21)
- Case Study Bipolar Disorder in Mentally Retarded Adolescents (1988) (21)
- Direct Health Care Costs for Children with Pervasive Developmental Disorders: 1996–2002 (2007) (21)
- Exome sequencing in obsessive–compulsive disorder reveals a burden of rare damaging coding variants (2021) (20)
- The developmental relationship between DHEA and visual attention is mediated by structural plasticity of cortico-amygdalar networks (2016) (20)
- Exome sequencing of 457 autism families recruited online provides evidence for novel ASD genes (2019) (20)
- Dehydroepiandrosterone impacts working memory by shaping cortico-hippocampal structural covariance during development (2017) (19)
- In Search of Biomarkers for Autism Spectrum Disorder (2018) (19)
- COMT Val158Met, BDNF Val66Met, and OPRM1 Asn40Asp and methamphetamine dependence treatment response: preliminary investigation. (2012) (19)
- Drug development for Autism Spectrum Disorder (ASD): Progress, challenges, and future directions (2021) (19)
- ADHD and executive functioning deficits in OCD youths who hoard. (2016) (19)
- Homeobox genes in obsessive‐compulsive disorder (2012) (18)
- Cognitive Effects of Stimulant, Guanfacine, and Combined Treatment in Child and Adolescent Attention-Deficit/Hyperactivity Disorder. (2016) (18)
- Self‐injurious behaviours in children and adults with autism spectrum disorder (ASD) (2018) (17)
- Using a Patient-Centered Outcome Measure to Test Methylphenidate Versus Placebo in Children with Autism Spectrum Disorder. (2017) (17)
- Testosterone and conduct problems. (1994) (16)
- Genome Wide Association Study (GWAS) between Attention Deficit Hyperactivity Disorder (ADHD) and Obsessive Compulsive Disorder (OCD) (2017) (16)
- The Neurobiological Basis of Attention-Deficit/Hyperactivity Disorder (2009) (15)
- Exposure to threshold doses of nicotine in utero: I. Neuroendocrine response to restraint stress in adult male offspring. (1994) (15)
- Genetics of pediatric anxiety disorders. (2012) (14)
- Derisking Psychiatric Drug Development: The NIMH's Fast Fail Program, A Novel Precompetitive Model. (2016) (14)
- Genome-wide association study of pediatric obsessive-compulsive traits: shared genetic risk between traits and disorder (2019) (14)
- Autonomic arousal in anxious and typically developing youth during a stressor involving error feedback (2017) (14)
- Is Persistent Motor or Vocal Tic Disorder a Milder Form of Tourette Syndrome? (2021) (14)
- Predicting Anxiety Diagnoses and Severity with the CBCL-A: Improvement Relative to Other CBCL Scales? (2015) (14)
- Sleep Sufficiency in Pediatric and Adolescent Tourette's Disorder: National Survey of Children's Health (2017) (14)
- Role of DHEA and cortisol in prefrontal-amygdalar development and working memory (2018) (13)
- Acute and Long-Term Cardiovascular Effects of Stimulant, Guanfacine, and Combination Therapy for Attention-Deficit/Hyperactivity Disorder. (2016) (13)
- Investigation of TSPO variants in schizophrenia and antipsychotic treatment outcomes. (2015) (13)
- Exposure to threshold doses of nicotine in utero: II. Neuroendocrine response to nicotine in adult male offspring. (1994) (13)
- Mediators of Treatment Outcomes for Anxious Children and Adolescents: The Role of Somatic Symptoms (2018) (13)
- A Single Dose, Randomized, Controlled Proof-Of-Mechanism Study of a Novel Vasopressin 1a Receptor Antagonist (RG7713) in High-Functioning Adults with Autism Spectrum Disorder (2017) (13)
- Attention–memory training yields behavioral and academic improvements in children diagnosed with attention-deficit hyperactivity disorder comorbid with a learning disorder (2017) (12)
- Elevated thyroid indices in children and adolescents with obsessive-compulsive disorder: effects of clomipramine treatment. (2005) (12)
- Secondary Outcomes From the Child/Adolescent Anxiety Multimodal Study: Implications for Clinical Practice (2018) (12)
- Self-reported executive function and hoarding in adults with obsessive-compulsive disorder. (2018) (12)
- Improving the methods for evaluating the safety of psychotropic medications in children and adolescents (2001) (12)
- Cognitive changes during topiramate therapy. (2001) (12)
- Distinguishing Fear Versus Distress Symptomatology in Pediatric OCD (2017) (11)
- Attention Deficit Hyperactivity Disorder : Fine Mapping Supports Linkage to 5 p 13 , 6 q 12 , 16 p 13 , and 17 p 11 (2004) (11)
- Prenatal stress prevents the desensitization of the corticosterone response to TFMPP by desmethylimipramine, but not by phenelzine, in adult male offspring. (1995) (11)
- Neuroleptic malignant syndrome in children and adolescents: two case reports and a warning. (1992) (11)
- Predictors of Caregiver Strain for Parents of Children with Autism Spectrum Disorder (2020) (11)
- Evaluating the Hierarchical Structure of ADHD Symptoms and Invariance Across Age and Gender (2019) (11)
- Deficiency in the opioid hypotheses of self-injurious behavior. (1991) (10)
- Effects of source of DNA on genotyping success rates and allele percentages in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS). (2007) (10)
- Iron homeostasis during risperidone treatment in children and adolescents. (2015) (10)
- Are the components of social reciprocity transdiagnostic across pediatric neurodevelopmental disorders? Evidence for common and disorder-specific social impairments (2018) (9)
- Sensitivity of the modified Children’s Yale–Brown Obsessive Compulsive Scale to detect change: Results from two multi-site trials (2016) (9)
- Trichotillomania comorbidity in a sample enriched for familial obsessive-compulsive disorder. (2019) (9)
- Neuroendocrine aspects of primary endogenous depression: VI. Receiver operating characteristic analysis of the cortisol suppression index versus the dexamethasone suppression test in patients and matched controls (1988) (9)
- CMAP ADHD and comorbid aggression algorithm [2] (2007) (9)
- Transcranial magnetic stimulation (TMS) therapy for autism: an international consensus conference held in conjunction with the international meeting for autism research on May 13th and 14th, 2014 (2015) (9)
- Optimizing behavior therapy for youth with Tourette’s disorder (2020) (9)
- Sleep functioning in adults with trichotillomania (hair-pulling disorder), excoriation (skin-picking) disorder, and a non-affected comparison sample. (2017) (9)
- Beliefs in vaccine as causes of autism among SPARK cohort caregivers. (2020) (9)
- Design and Subject Characteristics in the Federally-Funded Citalopram Trial in Children with Pervasive Developmental Disorders (2012) (8)
- Exposure to threshold doses of nicotine in utero: III. Augmentation of the prolactin and ACTH response to 8-OH DPAT by desipramine treatment is compromised in adult male offspring. (1996) (8)
- Clinical correlates and genetic linkage of social and communication difficulties in families with obsessive–compulsive disorder: Results from the OCD Collaborative Genetics Study (2014) (8)
- Defining tic severity and tic impairment in Tourette Disorder. (2020) (8)
- Dose-dependent effects of scopolamine on nocturnal growth hormone secretion in normal adult men : relation to δ-sleep changes (1991) (8)
- Effects of low-dose dexamethasone on sleep EEG patterns, plasma cortisol, and the TSH response to TRH in major depression. (1993) (8)
- Sex‐specific contribution of DHEA‐cortisol ratio to prefrontal‐hippocampal structural development, cognitive abilities and personality traits (2019) (7)
- Genome-wide association study identifies new locus associated with OCD (2021) (7)
- Lead intoxication psychosis in an adolescent. (1987) (7)
- Assessment of the Integrity of Study Blindness in a Pediatric Clinical Trial of Risperidone (2005) (6)
- Adolescent Sleep Patterns: The Search for Vulnerability Signatures for Depression in High-Risk Adolescents: Mechanisms and Significance (2002) (6)
- Dependent personality, separation anxiety disorder and other anxiety disorders in OCD. (2016) (6)
- Potential adverse effects of amphetamine treatment on brain and behavior: a review (2009) (6)
- 1 H MRSI evidence of metabolic abnormalities in childhood-onset schizophrenia (2003) (6)
- Clonidine side effect. (1997) (6)
- A Single Dose, Randomized, Controlled Proof-Of-Mechanism Study of a Novel Vasopressin 1a Receptor Antagonist (RG7713) in High-Functioning Adults with Autism Spectrum Disorder. (2017) (6)
- Changes in Sleep Problems Across Attention-Deficit/Hyperactivity Disorder Treatment: Findings from the Multimodal Treatment of Attention-Deficit/Hyperactivity Disorder Study. (2018) (5)
- Little Doubt That CBT Works for Pediatric OCD. (2020) (5)
- Beware of Over-Interpreting Negative Trials (2008) (5)
- No Apparent Cardiac Conduction Effects of Acute Treatment with Risperidone in Children with Autism Spectrum Disorder. (2015) (5)
- Up in Smoke? A Preliminary Open-Label Trial of Nicotine Replacement Therapy and Cognitive Behavioral Motivational Enhancement for Smoking Cessation Among Youth in Los Angeles (2013) (5)
- Author Correction: Large-scale targeted sequencing identifies risk genes for neurodevelopmental disorders (2020) (5)
- Cognitive control processes in behavior therapy for youth with Tourette's disorder. (2021) (5)
- Reduced Effect of Antidepressant Treatment on Prolactin Response to a Serotonin Agonist in Prepubertal Rats (1995) (5)
- The Interplay of Familial and Individual Risk in Predicting Clinical Improvements in Pediatric Anxiety Disorders (2018) (5)
- Management of Child and Adolescent Mood Disorders (1992) (5)
- Childhood and early-onset anxiety: treatment and biomarker studies. (2002) (5)
- High-throughput cognitive assessment using BrainTest.org: examining cognitive control in a family cohort (2013) (5)
- Transcranial magnetic stimulation ( TMS ) therapy for autism : an international consensus conference held in conjunction with the international meeting for autism research on May 13 th and 14 th , 2014 (2015) (4)
- Exploring Social Biomarkers in High-Functioning Adults with Autism and Asperger’s Versus Healthy Controls: A Cross-Sectional Analysis (2020) (4)
- Etiologic Aspects of Child and Adolescent Mood Disorders (1992) (4)
- Long-Term Service Use Among Youth Previously Treated for Anxiety Disorder. (2020) (4)
- AACAP OFFICIAL ACTION Practice Parameter for the Assessment and Treatment of Children and Adolescents With Autism Spectrum Disorder (2015) (3)
- Bipolar disorder in mentally retarded adolescents. (1988) (3)
- Erratum to “A testosterone-related structural brain phenotype predicts aggressive behavior from childhood to adulthood” [Psychoneuroendocrinology 63 (2016) 109–118] (2016) (3)
- A Randomized Controlled Feasibility Trial of Reminder-Focused Positive Psychiatry in Adolescents With Comorbid Attention-Deficit/Hyperactivity Disorder and Posttraumatic Stress Disorder. (2020) (3)
- Morning light therapy in adults with Tourette’s disorder (2021) (3)
- Pharmacotherapy for Autism Spectrum Disorders (2011) (3)
- 12.3 Target Engagement of AZD7325 in Adults With ASD (2018) (2)
- The dopamine receptor DRD4 gene. (2001) (2)
- General personality dimensions, impairment and treatment response in obsessive-compulsive disorder. (2019) (2)
- Gender Differences in Treatment-Seeking Youth with Autism Spectrum Disorder (2021) (2)
- 6.80 PLACEBO RESPONSE IN PEDIATRIC ANXIETY DISORDERS: RESULTS FROM THE CHILD AND ADOLESCENT ANXIETY MULTIMODAL STUDY (2016) (2)
- The Effect of Neurocognitive Function on Math Computation in Pediatric ADHD: Moderating Influences of Anxious Perfectionism and Gender (2018) (2)
- Home Situations Questionnaire--Autism Spectrum Disorder (2016) (2)
- Catecholamines in ADHD: a postscript. (1997) (2)
- Receiver Operating Characteristic Curve Analysis of Screening Tools for Bipolar Disorder Comorbid With ADHD in Schoolchildren (2020) (2)
- Age‐specific associations between oestradiol, cortico‐amygdalar structural covariance, and verbal and spatial skills (2019) (2)
- Neuroendocrine aspects of primary endogenous depression: IX. Receiver operating characteristic analysis of the dexamethasone suppression index vs. the dexamethasone suppression test in patients and controls (1990) (1)
- Peripubertal and adult male rats differ in their hypothalamic-pituitary response to cholinergic challenge. (1990) (1)
- Antipsychotic-induced weight gain: can the energy balance gene variants help us tip the scales? (2014) (1)
- 6.14 PHASE 3 RANDOMIZED CONTROLLED TRIAL OF BALOVAPTAN IN ADULTS WITH AUTISM SPECTRUM DISORDER (2020) (1)
- Citalopram Did Not Significantly Improve Anxiety in Children with Autism Spectrum Disorder Undergoing Treatment for Core Symptoms: Secondary Analysis of a Trial to Reduce Repetitive Behaviors. (2022) (1)
- 4.37 Nights of Sufficient Sleep in Children With Tourette’s Disorder: Findings From the National Survey of Children’s Health (2017) (1)
- 4.36 A Randomized, Double-Blind, Placebo-Controlled Study of the D1 Receptor Antagonist Ecopipam for Children and Adolescents With Tourette's Disorder (2017) (1)
- Neurochemical correlates of behavioral treatment of pediatric trichotillomania. (2020) (1)
- Association Analysis of Candidate Genes for ADHD on Chromosomes 5p13, 6q12, 16p and 17p (2007) (1)
- Dr. King and Colleagues Reply (1995) (1)
- Electrophysiological and Clinical Predictors of Methylphenidate, Guanfacine, and Combined Treatment Outcomes in Children With Attention-Deficit/Hyperactivity Disorder. (2022) (1)
- White matter microstructure shows sex differences in late childhood: Evidence from 6,797 children (2021) (1)
- Age Specific DTI Average Brain Atlases from the NIH MRI Study of Normal Brain Development (PedsDTI) (2011) (1)
- H-1 MRSI evidence of metabolic abnormalities in childhood-onset schizophrenia (2003) (1)
- P.2.109 A double-blind placebo-controlled trial of risperidone in autistic disorder (2003) (1)
- White matter microstructure shows sex differences in late childhood: Evidence from 6797 children (2022) (1)
- Psychiatric and Medical Profiles of Autistic Adults in the SPARK Cohort (2020) (1)
- Symptom Severity in Youths with Attention Deficit Hyperactivity Disorder Associated with Normalizing Effects of Treatment on fMRI Response during a Stop Signal Task (2019) (1)
- 2.1 AACAP Elaine Schlosser Lewis Award for Research on Attention-deficit Disorder Can We Improve Treatments for Attention-Deficit/Hyperactivity Disorder? (2017) (1)
- Corrigendum to “Drug development for Autism Spectrum Disorder (ASD): Progress, challenges, and future directions. [European Neuropsychopharmacology Volume 48, July 2021, Pages 3-31]” (2021) (1)
- Drug Treatments for Pervasive Developmental Disorders: Expanding the Evidence Base (2006) (1)
- P.1.c.012 A multi-center, observational study to explore the relationship between exploratory biomarkers and functional dimensions in adults with autistic spectrum disorders (2016) (1)
- Repeated scopolamine treatment does not enhance the acth response to physostigmine in rats (1993) (0)
- New Drug Targets and Potential Role of Pharmacogenetics in Autism Spectrum Disorder (2014) (0)
- 4.4 Optimizing Therapeutic Outcomes for Youth With Tourette’s Disorder (2018) (0)
- 5.0 Should I Use Genetic Data to Guide My Practice (2017) (0)
- Master Clinician: James T. McCracken, MD: Challenges in Autism Spectrum Disorder Treatment and Research (2016) (0)
- STX209 (Arbaclofen) for Autism Spectrum Disorders: An 8-Week Open-Label Study (2013) (0)
- Cmap adhd and comorbid aggression algorithm. Authors' reply (2007) (0)
- Association Analysis of Candidate Genes for ADHD on Chromosomes 5 p 13 , 6 q 12 , 16 p and 17 p (2007) (0)
- UNDERSTANDING THE OVERLAP AND THERAPEUTIC OPPORTUNITIES IN YOUTH WITH SUBSTANCE USE AND AUTISM SPECTRUM DISORDER (2021) (0)
- 0764 Changes In Sleep Patterns across Attention-deficit/hyperactivity Disorder Treatment: Findings from The MTA Study (2018) (0)
- Moving Beyond Symptom Subtypes: Testing a Common Dimension of Lifetime Ocd Symptoms (2022) (0)
- Brief Report: Social Disability in Autism Spectrum Disorder: Results from Research Units on Pediatric Psychopharmacology (RUPP) Autism Network Trials (2012) (0)
- 5.8 Deep Phenotyping of Children With ASD, Macrocephaly, and Phosphatidylinositol 3-Kinase/Protein Kinase B/Mammalian Target of Rapamycin (PI3K/AKT/mTOR) Pathway Mutations: Preliminary Findings (2018) (0)
- ! ! (2013) (0)
- COMMON PSYCHIATRIC COMORBIDITIES IN AUTISM SPECTRUM DISORDER: ADHD, ANXIETY, DEPRESSION, AND CATATONIA (2021) (0)
- Parental Anxiety as a Predictor of Medication and CBT Response for Anxious Youth (2014) (0)
- The cutting-edge of design and analysis: Penn State’s Methodology Center (2015) (0)
- Predicting Anxiety Diagnoses and Severity with the CBCL-A: Improvement Relative to Other CBCL Scales? (2014) (0)
- P.1.b.010 A possible GABAergic biomarker for adult autism spectrum disorder (2017) (0)
- 7.5 ASSESSMENT AND MANAGEMENT OF ADHD IN YOUTH WITH ASD (2019) (0)
- THE GUT MICROBIOTA IN AUTISM SPECTRUM DISORDER: FROM BENCH TO BEDSIDE (2020) (0)
- 6. Acetylcholine — affective disorder relationships: Recent findings (1998) (0)
- Academic Impairment and Impact of Treatments Among Youth with Anxiety Disorders (2014) (0)
- Exploring the Manifestations of Anxiety in Children with Autism Spectrum Disorders (2013) (0)
- PRECISION MEDICINE AND GENOMICALLY GUIDED TREATMENT IN AUTISM SPECTRUM DISORDER: ARE WE THERE YET? (2021) (0)
- PROLACTIN IN CHILDHOOD OBSESSIVE-COMPULSIVE DISORDER: CLINICAL CORRELATES AND RESPONSE TO CLOMIPRAMINE (1991) (0)
- Corrigendum to “Sleep functioning in adults with trichotillomania (hair-pulling disorder), excoriation (skin-picking) disorder, and a non-affected comparison sample” [Journal of Obsessive-Compulsive and Related Disorders 13 (2017) 49–57] (2017) (0)
- 2.41 Efficacy and Long-Term Clinical Outcome of Comorbid PTSD and ADHD After Reminder Focused Positive Psychiatry Intervention (2018) (0)
- Methylphenidate, Guanfacine, and Combined Treatment Effects on Electroencephalography Correlates of Spatial Working Memory Deficits in Attention-Deficit/Hyperactivity Disorder. (2022) (0)
- Design and Subject Characteristics in the Federally-Funded Citalopram Trial in Children with Pervasive Developmental Disorders (2011) (0)
- Running Head: Stimulant/Guanfacine Effects: EEG Effects of d-Methylphenidate, Guanfacine, and their Combination on EEG Resting State EEG Spectral Power in ADHD (2016) (0)
- Editorial Board (2010) (0)
- Dr. McDougle and Colleagues Reply (2006) (0)
- Children’s Yale–Brown Obsessive-Compulsive Scale--Pervasive Developmental Disorders Version (2017) (0)
- 2.2 Trial of Positive Psychiatry in Comorbid Attention-Deficit Hyperactive/Disorder (ADHD) With Posttraumatic Stress Disorder (PTSD) (2017) (0)
- 484. Autism is Associated With Reduced Gray Matter Volume in Sensory Brain Regions Among Males but Not Females (2023) (0)
- The Effect of Neurocognitive Function on Math Computation in Pediatric ADHD: Moderating Influences of Anxious Perfectionism and Gender (2018) (0)
- COMPLEX PRESENTATIONS OF ASD: BEYOND THE CORE FEATURES (2019) (0)
- Somatic Complaints in Anxious Youth (2013) (0)
- A pilot study of PEERS® for Careers: A comprehensive employment-focused social skills intervention for autistic young adults in the United States. (2022) (0)
- Developmental variation in testosterone:cortisol ratio alters cortical- and amygdala-based cognitive processes (2021) (0)
- Innovative Treatments in Child Psychiatry (2018) (0)
- CM Practice Parameter for the Assessment and Treatment of Children and Adolescents With Autism Spectrum Disorder (0)
- The Clinical Implications of Genetics in ADHD (2010) (0)
- IMPORTANT CO-OCCURRING PROBLEMS IN AUTISM SPECTRUM DISORDER: STRATEGIES FOR CHARACTERIZATION AND TREATMENT (2020) (0)
- CASE REPORT Lead Intoxication Psychosis in an Adolescent (1987) (0)
- Erratum: Correction (The Journal of clinical psychiatry (2011) 72 3 (388-396) PII: 19lcx13039) (2019) (0)
- 976. Estradiol, Cortico-Amygdalar Structural Networks and Cognitive Development (2017) (0)
- 6.7 AUTISM SPECTRUM DISORDER–FOCUSED AUGMENTED REALITY SMARTGLASSES SYSTEM FOR ENHANCING ENGAGEMENT AND PARENT-CHILD INTERACTION (2020) (0)
- GENETIC VARIANTS OF THE HISTAMINE 1 AND ALPHA 1A ADRENERGIC RECEPTORS AND DRUG‐INDUCED WEIGHT GAIN AMONG AUTISTIC CHILDREN.: 336 (2004) (0)
- Improving Precision in Autism Clinical Trials (2012) (0)
- Clinical Updates in Ncuropsychiatry NEWS FROM THE 50TH ANNUAL MEETING OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY ATOMOXETINE IMPROVES ADHD WITHOUT INCREASING SEVERITY OF COMORBID TICS (2013) (0)
- Knowledge Among Parents of Children Participating in a Randomized Clinical Trial (2005) (0)
- Hats Off: Journal Awards 2018 (2018) (0)
- Table of Contents (2020) (0)
- Dose-dependent effects of scopolamine on nocturnal growth hormone secretion in normal adult men: relation to delta-sleep changes. (1991) (0)
- What’s missing in autism spectrum disorder motor assessments? (2018) (0)
- S-62-3 Prenatal stress and responses to anti-depressants in adult offspring (1996) (0)
- COMPLEMENTARY AND INTEGRATIVE TREATMENTS FOR ASD AND ADHD: SELECTED RECENT RESEARCH (2019) (0)
- Prevalence and correlates of lifetime suicide attempt in obsessive-compulsive disorder with major depression. (2023) (0)
- P.7.d.011 Results from a phase I proof-of-mechanism study with a vasopressin 1A receptor antagonist in autism spectrum disorder (2015) (0)
- 9 The Tarjan Legacy of Prevention: An Update (2016) (0)
- Distinguishing Fear Versus Distress Symptomatology in Pediatric OCD (2016) (0)
- Correction to: Exploring Social Biomarkers in High‑Functioning Adults with Autism and Asperger’s Versus Healthy Controls: A Cross‑Sectional Analysis (2020) (0)
- Transcranial magnetic stimulation ( TMS ) therapy for autism : an international consensus conference held in conjunction with the international meeting for autism research on May 13 th and 14 (2015) (0)
- S.17.01 Evidence-based pharmacological treatments in autism spectrum disorders: symptom targets (2015) (0)
- Association of Serotonin Genotypes with Behaviors and Treatment Reponse (2010) (0)
- 336 GENETIC VARIANTS OF THE HISTAMINE 1 AND ALPHA 1A ADRENERGIC RECEPTORS AND DRUG-INDUCED WEIGHT GAIN AMONG AUTISTIC CHILDREN. (2004) (0)
- 51.2 NEURAL CORRELATES OF COGNITIVE-BEHAVIORAL THERAPY–RELATED CHANGES IN PEDIATRIC OBSESSIVE-COMPULSIVE DISORDER SYMPTOM DIMENSIONS (2016) (0)
- Anxiety in Children (1986) (0)
- O27. A Role for Bile Acid Signaling in Antipsychotic-Induced Weight Gain (2018) (0)
- INTEGRATING RECENT RESEARCH FINDINGS INTO THE CARE OF CHILDREN AND ADOLESCENTS WITH ANXIETY DISORDERS (2020) (0)
- Rare deleterious mutations of HNRNP genes result in shared neurodevelopmental disorders (2021) (0)
- EEG BIOMARKERS OF TREATMENT RESPONSE IN DEVELOPMENTAL DISORDERS (2019) (0)
- 77. Co-Occurring ASD+ADHD is Associated With Shared and Distinct Alterations in White Matter Microstructure (2023) (0)
- CORRECTION (2004) (0)
- Evidence for a Cholinergic Abnormality in Adolescent Major Depressives (1991) (0)
- Initiation of Pharmacotherapy Following CBT in Anxious Youth: Results From the Child/Adolescent Anxiety Multimodal Study (CAMS). (2022) (0)
This paper list is powered by the following services:
